CD8A and neoplasm: Previous study on multiple tumor models demonstrated that, despite the accumulation of CD8+ T cells and NK cells during tumor progression, the activation of these immune cells will be substantially inhibited by the binding of PD-Ls to them, which attenuates the anti-tumor activity of these cells (64).